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Abstract

Author Manuscript

The Affordable Care Act (ACA) is forecast to increase the demand for and utilization of substance
use disorder (SUD) treatment. Massachusetts implemented health reforms similar to the ACA in
2006 -2007 that included expanding coverage for SUD treatment. This study explored the impact
of Massachusetts health reforms from 2007 to 2010 on SUD treatment providers in Massachusetts,
who relied on fee-for-service billings for more than 50% of their revenue. The changes across
treatment facilities located in Massachusetts were compared to changes in other similar fee-forservice funded SUD treatment providers in Northeast states bordering Massachusetts and in all
other states across the US. From 2007-2010, the percentage changes for Massachusetts based
providers were significantly different from the changes among providers located in the rest of the
US for admissions, outpatient census, average weeks of outpatient treatment, residential/in-patient
census, detoxification census, length of average inpatient and outpatient stays, and provision of
medication assisted treatment. Contrary to previous studies of publicly funded treatment providers,
the results of this exploratory study of providers dependent on fee-for-service revenues were
consistent with some predictions for the overall effects of the ACA
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The Affordable Care Act (ACA) is forecast to increase the demand for and utilization of
substance use disorder (SUD) treatment service providers because it will require mental
health and SUD insurance coverage, apply Federal parity protections for SUD treatment,
and provide previously uninsured persons with treatment access through private health
insurance and Medicaid (U.S. Congress 2006; Beronio, et al. 2013). Increased coverage of
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payment for SUD treatment provided by the ACA may remove significant barriers that may
currently limit utilization of SUD treatment providers. Based on combined data for
2007-2010, the National Survey of Drug Use and Health estimated that 32% of those
perceiving an unmet need for SUD treatment cited lack of health coverage and inability to
afford the anticipated cost as primary barriers to obtaining available treatment (SAMHSA
2010). On a national basis, providing insurance coverage to these persons could increase the
patients utilizing SUD treatment providers by at least 12% (SAMHSA 2011a). The ACA
may also change the types and characteristics of SUD treatment service providers, since as
more persons are provided coverage, the portion of total SUD treatment services financed by
health insurance and Medicaid is likely to increase, while the portion supported by public
grants decreases (Buck 2011).

Author Manuscript

Since changes in treatment utilization for SUD would be indicators that the predictions
about the impact of the ACA are accurate, examining these changes is important. However,
the implementation of ACA has moved more slowly than might have been expected, and
there are yet to be reports in the secular media about changes in numbers of people seeking
treatment. The experience of Massachusetts, which earlier implemented legislation similar
to the ACA, may suggest national changes in SUD treatment as the ACA becomes fully
implemented across the nation.

Author Manuscript

In 2006-2007, Massachusetts expanded the Medicaid system and mandated coverage for
treatment of substance use and psychiatric disorders, foreshadowing similar provisions of
the ACA and the Mental Health Parity and Addictions Act of 2008 (Holaha & Blumberg
2006; SAMHSA 2014). The Massachusetts health reforms created a ‘natural experiment’
offering a partial test of predictions for the effects of ACA on SUD treatment providers
(Long & Stockley 2011)

Author Manuscript

Previous studies have shown limited effects of Massachusetts health care reform on SUD
treatment organizations (Capoccia et al. 2012). These works focused on fundamentally
different sets of SUD treatment providers than those considered in the present study.
Capoccia and colleagues (2012) examined a sample of large Massachusetts treatment
providers which derived over 60% of their revenues from state appropriations and block
grant funds and found that these organizations experienced minimal changes in new
admissions from 2006-2009. Across this sample, admissions increased by 19% only in 2010.
Although availability of increased insurance coverage might also increase length of patient
stay in treatment, the service units delivered within these organizations also remained
essentially unchanged over the study period (Capoccia et al. 2012). A separate research
report in 2010 also found that publicly funded facilities in Massachusetts experienced no
increase in demand for SUD treatment following health reform and suggested that
Massachusetts’ health reforms would likely benefit fee-for-service funded providers
(NASADAD 2010).
Officials in Massachusetts also have suggested that newly insured individuals might
primarily use fee-for-service SUD treatment providers (Stewart & Horgan 2011). Further,
the 2009-2010 revision of the Massachusetts SUD Strategic Plan predicted that expanded
coverage might shift patient demand from providers funded by public sector block grants to
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fee-for-service providers (State of Massachusetts 2010). Other research has also suggested
that increases in demand for treatment services due to expanded coverage under ACA may
occur primarily among treatment providers able to efficiently bill for third party
reimbursement and manage the flexibility and risks inherent to a fee-for-service business
model (Buck 2011).

Author Manuscript

These predictions suggest that patterns of admissions and service utilization due to
Massachusetts reforms may have been different within SUD treatment providers operating
on fee-for-service revenue, rather than public grant funds. This is the first research question
of this study. Thus the present study explores the impact of the Massachusetts health reforms
from their early stages in 2007 through implementation to 2010 in a sample of SUD
providers who relied on fee-for-service billings to insurance, Medicaid, Medicare, or selfpaying patients for more than 50% of their revenue. The second question is whether the
reforms affected fee-for-service dependent providers in Massachusetts differently than in
other locations. To answer this question, changes over 2007- 2010 in Massachusetts fee-forservice treatment providers were compared to changes over the same period in samples of
similar fee-for-service based treatment providers located both in northeastern states
contiguous to Massachusetts, and located across the US.

Author Manuscript

Many of the projected effects of the ACA and the Massachusetts reforms on SUD treatment
providers focus on expanded demand for services due to increased resources available to
patients. Greater resources available to SUD patients may be reflected in higher levels of
treatment admissions as well as on-going census levels (Buck 2011). Patients with more
insurance resources may stay in treatment longer, and higher levels of admissions may
require larger numbers of employees. Thus this study explored changes in the following
demand and capacity related variables in each group of fee-for-service dependent SUD
treatment providers: annual admission levels across all types of services; census levels for
residential/inpatient, outpatient and detoxification services; average length of stay for
residential/inpatient and outpatient services; and number of employees. If fee-for-service
dependent treatment providers attract larger numbers of patients, these providers may be
challenged to maintain high quality and comprehensive care (Ducharme, et al., 2007) which
includes both core SUD treatment services as well as medically assisted treatment options,
and wrap-around services covering co-occurring problems such as general medical
disorders, transportation, legal and other services. As a result, this study also explored
changes in the following quality of care related variables: provision of combined core and
wrap-around services; provision of medically assisted treatment; and percentage of
counselors with masters’ degrees. .

Author Manuscript

Methods
The National Treatment Center Study (NTCS)
Longitudinal information about the organizations studied was drawn from the National
Treatment Center Study (NTCS). The NTCS is a national study of organizations that
provide SUD treatment and which rely on fee-for service funding for more than 50% of their
revenue. The initial sample for this study was selected using a two-stage stratified process
where treatment providers were randomly sampled within population strata. Telephone
J Psychoactive Drugs. Author manuscript; available in PMC 2016 November 01.
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screening was used to establish eligibility for the study. Eligibility focused on treatment
organizations available in communities. SUD treatment providers included in the NTCS
must offer SUD treatment at ASAM Level 1 outpatient services or higher and receive more
than 50% of their annual revenues from fee-for-service billings to third parties including
health insurance, Medicaid, Medicare, and patient payments. Selection of participant
organizations excluded counselors in private practice, halfway houses, transitional living
facilities, methadone maintenance facilities, court-ordered driver education, correctional,
and VA facilities (Fields & Roman, 2010; Fields, et al., 2012)

Author Manuscript

Treatment providers participating in the NTCS were visited every 2 years. The data for this
study were collected during on-site visits and face-to-face interviews in 2007-2008 and
2009-2010. Data were collected from these treatment providers using interviews of
administrative and clinical directors conducted on-site. Both directors were provided with
revenue, census, and treatment services questions in advance of the interviews and asked to
consult organizational records for these data prior to the site visits. Interview guides and
informed consent procedures were approved by the University of Georgia Institutional
Review Board.

Author Manuscript

Data collected from each provider include measures of internal management practices,
revenues, patient referral sources, levels of care, and adoption of evidence-based practices
such as comprehensive care and medication assisted treatment. Empirical investigations of
organizations are often faced with a lack of archival data about constructs of interest, and
thus rely on data reported by key informants (Kumar, Stern & Anderson, 1993). Key
informants have been used in research studies to describe organizational variables including
innovation adoption, environmental influences, power of major suppliers and customers,
human resource practices, and quality management practices (Fields, Roman & Blum, 2012;
Fields & Roman, 2010; Phillips, 1981).
To maintain sample size over the life of the NTCS, replacements for organizations that left
the sample through closure or other attrition were randomly drawn from updated directories
of providers. In 2007-2008, 345 fee-for service dependent treatment providers participated
in the NTCS; in 2009-2010, 329 treatment centers were involved. Since the focus of the
study was on changes occurring across a group of providers between 2007 and 2010, it was
necessary that the same providers were present for both time periods (Singer & Willett
2003). A sample of 274 SUD treatment providers provided NTCS data in both 2007 and
2010 was available for analysis, representing retention of 79% across the two data collection
periods. Massachusetts sample

Author Manuscript

Nine SUD treatment providers located in Massachusetts provided NTCS data in 2007 and
2010 and these providers form the study sample. In order to assess the extent to which the
study sample is representative of all SUD treatment providers in Massachusetts Table 1
compares the study sample of Massachusetts SUD treatment providers with 307
Massachusetts treatment organizations that responded to the National Survey of Substance
Abuse Treatment Services (N-SSATS) in 2010.

J Psychoactive Drugs. Author manuscript; available in PMC 2016 November 01.

Fields et al.

Page 5

Author Manuscript

As this table shows, the providers in the study sample were similar to Massachusetts NSSATS-2010 respondents in for-profit/non-profit status, and in size distribution. However,
organizations in the study sample were larger on average and more likely to offer outpatient,
residential/inpatient, and detox services than overall N-SSATS-2010 Massachusetts
respondents. Further, providers in the Massachusetts sample received 50% or more of
revenues from fee-for service billings while Massachusetts N-SSATS participants may have
received larger percentages of revenue from public funds. (N-SSATS 2010 state level data
does not provide the SUD treatment provider percentage of revenue by source). The NSSATS data at the state level are also aggregated across all participating survey respondents.
In 2010, Massachusetts N-SSATS respondents included 4 providers operated by the
Department of Veterans Affairs and 1 operated by the department of Defense. Federally
operated SUD treatment provides were excluded from the NTCS sampling frame. Inclusion
of the federally operated treatment providers may have unknown impact in the comparison
of the Massachusetts study sample with the Massachusetts N-SSATS respondents shown in
Table 1.

Author Manuscript

Comparison samples

Author Manuscript

The NTCS comparison sample for Northeastern states contained 32 SUD treatment
providers who provided NTCS data in both 2007 and 2010 and that were located in the
states of New York, New Hampshire, Vermont, Maine, and Connecticut. These NTCS
participants also received 50% or more of their revenues from fee-for-service billing. These
states also had comparable levels of SUD admissions per 100,000 residents to Massachusetts
over the same time period (SAMHSA 2011b). The SUD treatment providers in the
Massachusetts study sample were somewhat larger (mean = 77 employees) than the SUD
treatment providers in the NTCS participants in the Northeast comparison sample (mean =
53 employees). The Massachusetts SUD treatment providers in the study sample obtained
92% of revenue fee-for-service, a larger percentage than the Northeast comparison sample
SUD treatment providers (79% on average)
The comparison sample for all of the US outside Massachusetts contained 265 SUD
treatment providers who provided NTCS data in both 2007 and 2010. These NTCS
participants also received 50% or more of their revenues from fee-for-service billing. The
SUD treatment providers in the Massachusetts study sample were somewhat larger (mean =
77 employees) than the SUD treatment providers in the NTCS participants in the
comparison sample for the rest of the US (mean = 39 employees).

Author Manuscript

The Massachusetts treatment centers obtained 92% of revenue fee-for-service, a larger
percentage than fee-for-service dependent SUD treatment providers in the rest of the US
(82% on average). Neither of these measures (mean employees and percent fee-for-service
revenue) was significantly different from those in the comparison samples of SUD treatment
providers in the Northeast and US.
Measures
Annual admissions—These are total admission to all forms of treatment offered by the
SUD treatment provider in the past year. In order to capture the changes in the treatment
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system over 2007-2010, the aggregate admissions were summed across the Massachusetts
sample and across the comparison samples.
Residential/Inpatient census—Clinical directors were asked to provide the current
patient census for each of inpatient SUD treatment (less than 30 days in residence),
residential SUD treatment (greater than 30 days) and inpatient psychiatric services. The
summed values was used as a point estimate of the treatment center census for residential/
inpatient services. The aggregate residential/inpatient census was summed across the
Massachusetts and comparison samples.

Author Manuscript

Outpatient census—Clinical directors provided current patient census levels for partial
hospitalization (day treatment), intensive outpatient, and traditional outpatient. These values
were summed as a point estimate of the treatment center outpatient census. The aggregate
outpatient census was summed across the Massachusetts and comparison samples.
Detox census—Clinical directors of each treatment center also provided current patient
census for inpatient and outpatient detox services. These were summed to form the detox
census for each center. The aggregate census was summed across the Massachusetts and
comparison samples.
Average inpatient length of stay—Clinical directors were asked to provide the average
length of stay in days for each of type of residential/inpatient treatment. These values were
averaged for each treatment center to estimate the average inpatient length of stay measures
in days. The values for treatment centers were then averaged across centers in the
Massachusetts and comparison samples.

Author Manuscript

Average outpatient length of stay—Clinical directors provided the average patient
length of stay in weeks for each type of outpatient treatment. These values were averaged
for each treatment center to estimate the average outpatient length of stay. The values for
treatment centers were then averaged across centers in the Massachusetts and comparison
samples.

Author Manuscript

Comprehensive care index—Following Ducharme and colleagues (2007) the extent of
comprehensive care used an index of core and ancillary services. This index summed
indicators of use of the ASI at intake/assessment; patient random drug testing; one or more
12-step groups; use of buprenorphine, naltrexone, methadone, disulfiram, or SSRIs,
aftercare/continuing care; childcare; transportation assistance; treatment for HIV/AIDS
patients; integrated care for dual diagnosis patients; and links with primary medical care;
employment services; financial aid; family counseling; and legal services. The index values
for treatment centers were averaged across centers in each sample.
Percentage providing medication assisted treatment—Clinical directors indicated
if their treatment center prescribes or dispenses any medications for SUD treatment. The
responses were coded 1 if yes and 0 if no. The percentage in each sub-sample offering this
treatment approach was calculated.
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Percentage of counselors with masters degrees—Administrative directors
provided the number of SUD counselors with masters’ degrees working in each center. This
number was divided by the total number of counselors to obtain the percentage.
Total employees—Administrative directors were asked for the total number of employees
working in each organization (full-time and part –time, both clinical and non-clinical).
These totals were summed across all organization in the Massachusetts and both comparison
samples.
Analytic Plan

Author Manuscript

To explore impacts of Massachusetts health reforms on the fee-for-service funded system of
providers, this study investigated changes in measures aggregated across the organizations
within each sub-sample in each time period. That is, the research question is directed at
estimating the effects of health reform on fee-for-service dependent SUD providers within
each of the geographic areas (Massachusetts, contiguous northeastern states, and the rest of
the US). This approach does not claim that the individual centers in the subsample are
representative of all fee-for-service dependent providers in Massachusetts, the contiguous
Northeastern states, or the rest of the US. The sum of the values within each sub-sample is
used as a point estimate of the population value (Wallace & Silver 1988). This approach
treats the changes in aggregated values of each of the study variables across centers in each
sub-sample as estimates of the changes occurring within fee-for-service treatment provider
system in each geographic area. This follows the approach taken in previous studies of
Massachusetts health reforms (Capoccia, et al. 2012). Since this study focuses on differences
in the changes over time between the geographic sub-samples, the extent and direction of
percentage changes in key treatment system variables were assessed for statistical
significance using t-tests (Nunnally 1959)

Author Manuscript

Results

Author Manuscript

Massachusetts-based SUD treatment providers primarily funded by fee-for service revenues
had substantially increased admissions from 2007-2010. These treatment organizations also
increased the number of outpatients in treatment, and the average weeks that these patients
stayed in treatment. Both changes are consistent with patients using increased access to
insurance coverage to enter and remain in treatment. However the Massachusetts treatment
organizations had reduced residential/in-patient and detoxification census levels and these
patients averaged shorter stays. Within this group of Massachusetts providers, total
employees were reduced by 18%. These changes are described in the left-hand portion of
Table 2.
Compared to treatment providers in adjoining states, Massachusetts facilities had larger
changes in admissions, increases in outpatient census, decreases in average length of
residential/inpatient stay, decreases in detox patients. In addition, the Massachusetts
providers decreased the number of employees, while similarly funded organizations in the
Northeast increased.

J Psychoactive Drugs. Author manuscript; available in PMC 2016 November 01.

Fields et al.

Page 8

Author Manuscript

The patterns of changes in Massachusetts based treatment providers from 2006 -2010 are
compared to the sample of similarly fee-for–service funded treatment centers located in the
rest of the US in Table 3. Admissions increased in the Massachusetts centers, but declined in
similarly funded organizations in other states; outpatient census and average length of stay
both increased in the Massachusetts sample, but outpatient census decreased while length of
stay in treatment remained essentially constant in other states. Finally, the detoxification
census in the Massachusetts centers declined by 11%, but increased by 89% in treatment
centers located elsewhere.

Author Manuscript

There were no significant differences between Massachusetts treatment providers and those
in the Northeast or the rest of the US in the changes in two indicators. These were the extent
to which a center provides comprehensive care (basic SUD treatment essentials as well as
wrap-around services) and percentage of counselors with masters’ level education. Two
other indicators of treatment quality increased significantly more in Massachusetts providers
than in treatment centers in other states. These were provision of medication assisted
treatment and average outpatient length of stay.

Discussion

Author Manuscript

The patterns of changes following implementation of health care reforms for Massachusetts
treatment organizations which derive most of their income from fee-for-service funding are
consistent with the effects forecasted for ACA. Specifically, across our sample of fee-forservice treatment organizations in Massachusetts, patient admissions outpatient census,
average outpatient weeks of stay in treatment, and provision of medication assisted
treatment increased significantly more than across a sample of SUD treatment providers
located across the US. At the same time, residential/inpatient census and average length of
stay, as well as detox census decreased across the Massachusetts providers and these
changes differed significantly from the changes for treatment providers across the country.
The changes across Massachusetts providers also differed significantly from change patterns
within treatment providers reliant on fee-for-service funding located within the Northeast
US. The northeast sample include SUD treatment providers located in Vermont and Maine,
states which implemented more limited forms of health care reforms than Massachusetts..

Author Manuscript

These differences in changes between Massachusetts and the sample of SUD treatment
centers across the US are consistent with changes forecasted due to the ACA (Buck 2011).
These forecasts predict that health care reform Medicaid expansion and parity requirements
will result in greater aggregate demand for SUD treatment since more prospective patients
would now have means of payment. They also suggest a shift away from residential
treatment (which is not often covered by Medicaid plans or health insurance) and increased
emphasis on medically-assisted treatment. The changes in the samples of treatment
organizations studies here also differed from previously reported patterns over the same time
period in a set of publicly funded treatment SUD treatment providers within Massachusetts
(Capoccia et al. 2012)
Although these analyses were explored in samples that may not be representative of all feefor-service revenue based providers in each location, the differences observed tend to
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support the perspective that health care reform may have greatest impact on those SUD
treatment providers whose business model is based on billing third parties for
reimbursement. Expanded insurance coverage may not only increase admissions at these
facilities, but also enable persons already in treatment to remain for longer periods, a
positive implication as longer engagement in outpatient treatment is associated with better
treatment outcomes. It is notable that from 2007-2010, two indicators of treatment quality
(average outpatient length of stay and provider offering medication assisted treatment) had
larger positive changes in the Massachusetts sample compared the centers located across the
US. The changes in two other indicators of quality (provision of comprehensive care and
percentage of counselors with masters’ level education) were not different across the
Massachusetts centers compared to SUD treatment providers located across the country.
However, the negative percentage change in employees within the Massachusetts centers
was significantly different from the positive change in employees across the sample of SUD
treatment providers across both the Northeast and US as a whole. The decrease in overall
SUD treatment staff across the Massachusetts providers does bring into question the stability
of these quality indicators.

Author Manuscript

These results suggest that health care reform policies and funding incentives resulted in
changes in the types of SUD treatment handled by different types of providers. For example,
a goal of the Massachusetts Strategic Plan for Substance Abuse was a shift from inpatient
episodes of care to outpatient settings at treatment centers (State of Massachusetts 2010).
Across the fee-for-service Massachusetts providers in this study, residential/inpatient census
and average length of stay decreased. In addition, although Medicaid expenditures for detox
services increased within Massachusetts as a whole from 2007-2010, the detox census in the
study sample decreased over the same period (Capoccia et al. 2012). These changes are
consistent with previous research suggesting that health reforms shifted SUD treatment
emphases from acute-care to a recovery-oriented system-of-care model focused more on
outpatient care.
Some of these changes may also reflect effects of Massachusetts’ 2008 implementation of a
managed care system in conjunction with health reforms. Managed care covering SUD
treatment may have imposed treatment guidelines and incentives for use of lower-cost
treatment methods, creating pressures that shifted more acute cases requiring inpatient care
to public sector supported treatment centers (Long & Stockley 2011). Treatment providers
that are heavily reliant on reimbursement sources may be very responsive to policies and
procedures that affect third party payments and fine-tune treatment practices accordingly.

Author Manuscript

While our data do not have the precision to measure the various factors that might have
contributed to the decline in the organizational workforces among the treatment providers
we examined, it appears logical that the reduced delivery in these centers of both detox and
residential services effected the management decisions to make staff reductions. This
highlights the possibly greater economic sensitivity to patient flow in centers primarily
dependent on fee for service revenues as compared to those benefiting from public revenues.
Whether detox and residential patients were shifted to the public sector is beyond the scope
of our data, but the small changes in caseload revealed in the publicly funded organizations
studied by Capoccia and his colleagues do not offer strong support to this possibility.
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The sample of fee-for-service funded SUD treatment providers in Massachusetts is small,
comprising 3% of the 307 SUD treatment providers in Massachusetts. While this small
sample is similar in type of ownership and size distribution to the N-SATSS 2010 inventory
of Massachusetts facilities, it may differ in other unmeasured ways. These unmeasured
variables could account for the changes in the Massachusetts study sample as well as the
differences in changes between the study sample and other comparable treatment providers
in the northeast and the rest of the US. Although healthcare reforms including increased
coverage for SUD treatment were implemented in Massachusetts in 2006, we do not have
information about the familiarity of the sampled treatment providers with reforms, the extent
to which these facilities helped prospective patients obtain coverage, or the extent of
premium costs or co-pay requirements faced by SUD patients. Data about the sources of
revenue, census levels, staffing, and the dependence on fee-for-service billings were
provided by administrative directors acting as key informants. While these directors were
provided with these questions in advance and asked to consult organizational records, it is
possible that these key informants did not have completely accurate data. The sources of
revenue, census levels, or utilization levels were not verified with insurance claims data or
other publicly available information about the SUD treatment providers. While the
comparison of the changes in Massachusetts providers with similar providers located
elsewhere helped control for effects of other trends, the small sample size limited the ability
to isolate such other effects through techniques such as multivariate regression.
Conclusions

Author Manuscript

Overall, our results support the forecast that the ACA, Medicaid expansion, and increased
coverage requirements may contribute to increased admissions and services provided by
SUD treatment providers who focus on reimbursements from health insurance, self-paying
clients, and Medicaid/Medicare. The results suggest also that these centers may shift
treatment emphasis in response to reimbursement policies and priorities. In general,
providers which are more reliant on income from third party billings may be responsive to
policy driven changes in revenue opportunities while working within the challenge of
managed-care environments. However, the treatment system overall may need further
support and incentives for expansion, since Massachusetts rates of unmet treatment need
from 2002-2010 showed no significant decline (Zhu et al. 2010).
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21%

Pct. for-profit

Pct. < 30 patients
44%

190

Average patients per organization

Pct. > 60 patients

55%

Pct. offering detox

33%

67%

Pct. offering residential/inpatient

4

89%

Pct. offering outpatient treatment

1708

9

43%

38%

22%

128

30%

48%

63%

39444

307

2
N-SSATS Massachusetts

The cut-points of 30 and 60 patients are used by N-SSATS and presented here in order to compare the size distribution of the study sample with the size distribution of the N-SSATS participants.

4

Total patients in treatment for N-SSATS respondents is a point-prevalence report of the patients receiving or enrolled in treatment on March 31, 2010. Total patients in treatment for the study sample is
also a point-prevalence report of the patients receiving or enrolled in treatment on the date of the site visit and interviews with administrative and clinical directors per the NTCS (National Treatment Center
Study) protocol. These dates vary across 2009-2010

3

The N-SSATS comparison data are drawn from the national Survey of Substance Abuse treatment Services (N-SSATS): 2010 Data on Substance Abuse Treatment Facilities. The data on the variables
shown are reported at the state level by N-SSATS aggregated across all responding treatment providers. In 2010, the 307 responding SUD treatment providers in Massachusetts included 5 Federally
operated facilities (4 operated by Department of Veterans Affairs and 1 by the Department of Defense). Federal facilities were excluded from the sampling frame and protocol used to collect data for the
study sample.

2

Data describing the study sample are drawn from the sample of treatment providers in the National Treatment Center Study (NTCS) of SUD treatment providers who received more than 50% of revenues
from fee-for service billings and which participated in on-site visits and interviews in both 2007 and 2010.

1

3

Total patients in treatment

Number of organizations

Study sample

1

Comparison of Massachusetts study sample to N-SSATS 2010 Massachusetts respondents.
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69%
753

Total employees

619

67%

78%

13.7

10.6

9.6

155

1392

161

22095

2009-10

−18%

−3%

17%

83%

68%

−35%

−11%

26%

−25%

37%

% Change

1427

56%

75%

8

17

41

62

5691

431

31803

2007-8

1680

56%

78%

14.8

23.2

39.7

72

4138

358

31451

2009-10

18%

0%

4%

85%

34%

−4%

16%

−27%

−17%

−1%

% Change

2

Northeast comparison sample (N=32)

2.23

*

0.21

1.41

0.15

1.91

3.92

**

3.56

**

6.21

**

0.55

**

4.58

t value for difference in % change

Northeast comparison sample is from the National Treatment Center Study (NTCS) of SUD treatment providers who received more than 50% of revenues from fee-for service billings, participated in onsite visits and interviews in both 2007 and 2010, and were located in states contiguous to Massachusetts.

2

1
Massachusetts study sample is from the National Treatment Center Study (NTCS) of SUD treatment providers who received more than 50% of revenues from fee-for service billings and which
participated in on-site visits and interviews in both 2007 and 2010.

p < .01

**

p < .05

*

67%

Average % Counselors with Masters

7.5

Medication assisted treatment.

6.3

14.7

Average Residential/IP length of stay (Days)

Comprehensive Care Index

174

Detox patient census

Average OP Length of stay (Weeks)

216
1109

Outpatient (OP) census

16112

Residential/IP census

Total admissions

2007-8

Massachusetts study sample (N=9)

1

Changes in Massachusetts treatment providers compared to similar treatment providers in Northeastern states
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69%
753

Average % Counselors with Masters

Total employees

619

67%

78%

13.7

10.6

9.6

155

1392

161

22095

2009-10

−18%

−3%

17%

83%

68%

−35%

−11%

26%

−25%

37%

% Change

9653

50%

59%

7.35

13.2

35.3

760

20142

3639

291222

2007-8

10475

52%

59%

13.6

13.6

31.3

1437

20009

3367

217805

2009-10

9%

5%

0%

85%

3%

−11%

89%

−1%

−7%

−25%

% Change

2

Other states in USA (N=265)

**

2.30

*

0.33

7.78

**

0.16

10.30

**

2.22

*

29.80

5.97

**

2.03

*

**

21.97

t value for difference in % change

Northeast comparison sample is from the National Treatment Center Study (NTCS) of SUD treatment providers who received more than 50% of revenues from fee-for service billings, participated in onsite visits and interviews in both 2007 and 2010, and were located in states contiguous to Massachusetts.

2

Massachusetts study sample is from the National Treatment Center Study (NTCS) of SUD treatment providers who received more than 50% of revenues from fee-for service billings and which
participated in on-site visits and interviews in both 2007 and 2010.

1

p < .01

**

p < .05

*

67%

Medication assisted treatment.

7.5

14.7

Average Residential/IP length of stay (Days)

Comprehensive Care Index

174

Detox patient census

6.3

1109

Outpatient (OP) census

Average OP Length of stay (Weeks)

216

16112

Residential/IP census

Total Admissions

2007-8

Massachusetts study sample (N=9)

1

Changes in Massachusetts SUD treatment providers compared to similar treatment providers in all other USA states
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